|
“Therapeutic Polymeric Nanoparticles with mTOR Inhibitors and Methods of …
4-traders (press release) For example, disclosed herein is a therapeutic nanoparticle comprising about 1 to about 20 weight percent of a therapeutic agent (such as for example sirolimus, temsirolimus, or everolimus) and about 50 to about 99 weight percent of a biocompatible … |
Cold causes Red Cross blood donation shortfall – York Dispatch
WDTVCold causes Red Cross blood donation shortfallYork DispatchCold causes Red Cross blood donation shortfall. By GREG GROSS. 505-5433/@ydcrime. Updated: 01/08/2014 08:47:22 PM EST. The severe cold and snow not only wreaked havoc on nearly everyone, it…
Anti-CD20 Antibody + Chemo Benefits CLL With Comorbidity – Doctors Lounge
Anti-CD20 Antibody + Chemo Benefits CLL With ComorbidityDoctors LoungeFor patients with previously untreated chronic lymphocytic leukemia and coexisting conditions, combining an anti-CD20 antibody (rituximab or obinutuzumab) with chemotherapy is associ…
Waters Corporation : Study Findings from Waters Corporation Broaden … – 4-traders (press release)
|
Waters Corporation : Study Findings from Waters Corporation Broaden …
4-traders (press release) According to news reporting originating from Milford, Massachusetts , by NewsRx correspondents, research stated, “LC-MS is increasingly used for therapeutic drug monitoring of tacrolimus. A recent summary from an international proficiency-testing … |
Khon Kaen Sugar Industry PCL : Findings from Khon Kaen University in the Area … – 4-traders (press release)
|
Khon Kaen Sugar Industry PCL : Findings from Khon Kaen University in the Area …
4-traders (press release) The news reporters obtained a quote from the research from Khon Kaen University , “It has been reported that the clearance of tacrolimus in patients with the CYP3A5*1 allele was similar to 2.5-fold greater than that in those with the CYP3A5*3/*3 genotype. |
Messages link NJ Gov. Chris Christie aide to creation of traffic jam – Greensboro News & Record
|
Messages link NJ Gov. Chris Christie aide to creation of traffic jam
Greensboro News & Record Fort Lee Councilwoman Ila Kasofsky said she knows of one woman who couldn’t get over the bridge to be with her husband, who was undergoing a stem cell transplant, and another who couldn’t get to New York to be with her son as he went through kidney … |
DC community calendar, Jan. 9 to 16, 2014 – Washington Post
DC community calendar, Jan. 9 to 16, 2014Washington PostCathedral pipe organ recital, James Hicks performs organ music from Sweden by Erik Alvin, Yngve Skold, Fredrik Sixten, Erlend von Koch and Oskar Lindberg on the 10,650-pipe great organ. 5:15 p.m.,…
Seattle Genetics Nabs $25M More From AbbVie for Souped Up Antibodies – DailyFinance
Drug Discovery & Development |
Seattle Genetics Nabs $25M More From AbbVie for Souped Up Antibodies
DailyFinance Seattle Genetics is best known for its one successful marketed cancer drug, but it has been busy working behind the scenes for years on new technologies for making souped-up antibodies against cancer. Now AbbVie has agreed to pay $25 million to gain … Seattle Gentics-AbbVie Deal ExpandedZacks.com Seattle Genetics Further Expands Antibody-Drug Conjugate Collaboration with …Wall Street Journal Seattle Genetics and AbbVie Broaden PartnershipPharmaceutical Processing |
Two-Sizes-Too-Small 'Grinch' Effect Hampers Heart Transplantation Success – Newswise (press release)
Philly.com |
Two-Sizes-Too-Small ‘Grinch’ Effect Hampers Heart Transplantation Success
Newswise (press release) Newswise — Baltimore, MD – January 8, 2014 – Current protocols for matching donor hearts to recipients foster sex mismatching and heart size disparities, according to a first-of-its kind analysis by physicians at the University of Maryland School of … Finding the Right Heart for TransplantationdailyRx |
Seattle Genetics Nabs $25M More From AbbVie for Souped Up Antibodies – Motley Fool
Drug Discovery & Development |
Seattle Genetics Nabs $25M More From AbbVie for Souped Up Antibodies
Motley Fool Seattle Genetics (NASDAQ: SGEN ) is best known for its one successful marketed cancer drug, but it has been busy working behind the scenes for years on new technologies for making souped-up antibodies against cancer. Now AbbVie (NYSE: ABBV ) has … Seattle Gentics-AbbVie Deal ExpandedZacks.com Seattle Genetics, AbbVie Broaden PartnershipDrug Discovery & Development |